Evidence map›Paper›PMID 27580257›Full record

ReviewCurrent opinion in biotechnology2017

The future of NMR-based metabolomics.

John L Markley, Rafael Brüschweiler, Arthur S Edison, Hamid R Eghbalnia, Robert Powers, Daniel Raftery, David S Wishart

Abstract readReview
In one paragraph

Review in Current opinion in biotechnology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 380 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
380citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

380 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. A Stable Isotope Tracing Primer for the Mass Spectrometrist.Annual review of analytical chemistry (Palo Alto, Calif.) · 2026
    Review
  17. Article
  18. Exometabolome variation in the fungal pathogen of humansApplied and environmental microbiology · 2026
    Article
  19. Article
  20. Review

320 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

John L MarkleyBiochemistry Department, University of Wisconsin-Madison, 433 Babcock Drive, Madison, WI 53706, USA. Electronic address: jmarkley@wisc.edu.
Rafael BrüschweilerDepartment of Chemistry & Biochemistry, The Ohio State University, 151 W. Woodruff Ave., Columbus, OH 43210, USA; Department of Biological Chemistry & Pharmacology, The Ohio State University, 151 W. Woodruff Ave., Columbus, OH 43210, USA.
Arthur S EdisonDepartment of Genetics and Biochemistry, Institute of Bioinformatics and Complex Carbohydrate Center, University of Georgia, 315 Riverbend Rd, Athens, GA 30602, USA.
Hamid R EghbalniaBiochemistry Department, University of Wisconsin-Madison, 433 Babcock Drive, Madison, WI 53706, USA.
Robert PowersDepartment of Chemistry, University of Nebraska-Lincoln, 722 Hamilton Hall, Lincoln, NE 68588, USA.
Daniel RafteryDepartment of Anesthesiology & Pain Medicine, 850 Republican St, University of Washington, Seattle, WA 98109, USA.
David S WishartDepartment of Biological Sciences, University of Alberta, Edmonton, AB, Canada T6G 2E8; Department of Computing Science, University of Alberta, Edmonton, AB, Canada T6G 2E8.

Funding

Translational Bioimaging Core Shared ResourceP30CA015704 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Eric Collisson · 1985 to 2026
$296.4M
The S. aureus biofilm lifecycleP01AI083211 · NIAID · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI BAYLES, KENNETH W. · 2009 to 2023
$32.1M
PILOT STUDY--CLINICAL NUTRITION RESEARCHP30DK035816 · NIDDK · UNIVERSITY OF WASHINGTON · PI Ellen A Schur · 1986 to 2026
$30.4M
THE REDOX-MEDIATED REGULATION OF IRON-RESPONSIVE GENE EXPRESSION IN LIVERP20RR017675 · NCRR · UNIVERSITY OF NEBRASKA LINCOLN · PI BECKER, DONALD F · 2002 to 2011
$20.4M
TRD3 NMRbox: Bayesian AnalyticsP41GM111135 · NIGMS · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI HOCH, JEFFREY C · 2015 to 2024
$14.0M
TR&D 3: TECHNOLOGY DEVELOPMENT FOR NMR STUDIES OF SMALL MOLECULES (METABOLOMICS, NATURAL PRODUCTS, METABOLITE-PROTEIN INTERACTIONS) pp.537-585 P41GM103399 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI BUTCHER, SAMUEL E · 2012 to 2019
$9.4M
Southeast Resource Center for Integrated Metabolomics (SECIM)U24DK097209 · NIDDK · UNIVERSITY OF FLORIDA · PI EDISON, ARTHUR S, YOST, RICHARD A. · 2013 to 2017
$9.2M
The BMRB as an evolving resource for biomolecular structure-function researchR01GM109046 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI HOCH, JEFFREY C · 2014 to 2022
$6.6M
Targeting Tumor-Stromal Metabolic Cross-Talk in Pancreatic CancerR01CA163649 · NCI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Pankaj Kumar Singh · 2012 to 2026
$5.4M
Redox Biology CenterP30GM103335 · NIGMS · UNIVERSITY OF NEBRASKA LINCOLN · PI BECKER, DONALD F · 2012 to 2016
$4.3M
New hybrid methods for the improved and integrated analysis of complex metabolomics mixturesR01GM066041 · NIGMS · OHIO STATE UNIVERSITY · PI BRUSCHWEILER, RAFAEL · 2002 to 2019
$3.3M
Advanced Methods in NMR-Based MetabolomicsR01GM085291 · NIGMS · UNIVERSITY OF WASHINGTON · PI RAFTERY, DANIEL · 2008 to 2016
$2.7M
NCI NIH HHS F31 CA157045NCI NIH HHS P30 CA015704NCI NIH HHS R01 CA163649NCRR NIH HHS P20 RR017675NIAID NIH HHS P01 AI083211NIAID NIH HHS R01 AI087668NIDDK NIH HHS P30 DK035816NIDDK NIH HHS U24 DK097209NIGMS NIH HHS P30 GM103335NIGMS NIH HHS P41 GM103399NIGMS NIH HHS P41 GM111135NIGMS NIH HHS R01 GM066041NIGMS NIH HHS R01 GM085291NIGMS NIH HHS R01 GM109046
6 · The paper itself

Abstract

The two leading analytical approaches to metabolomics are mass spectrometry (MS) and nuclear magnetic resonance (NMR) spectroscopy. Although currently overshadowed by MS in terms of numbers of compounds resolved, NMR spectroscopy offers advantages both on its own and coupled with MS. NMR data are highly reproducible and quantitative over a wide dynamic range and are unmatched for determining structures of unknowns. NMR is adept at tracing metabolic pathways and fluxes using isotope labels. Moreover, NMR is non-destructive and can be utilized in vivo. NMR results have a proven track record of translating in vitro findings to in vivo clinical applications.

Indexed as

AnimalsBiomarkersHumansMagnetic Resonance ImagingMagnetic Resonance SpectroscopyMetabolic Networks and PathwaysMetabolomicsBiomarkers

Identifiers

PMID27580257
PMCPMC5305426

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.